Cite
MLA Citation
Farah Latif et al.. “Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis.” Expert review of anticancer therapy, vol. 22, no. 2, 2022, pp. 229–235. http://access.bl.uk/ark:/81055/vdc_100150562988.0x000028